CompletedPhase 1NCT04090684

Ciprofloxacin/Celecoxib Combination in Patients With ALS

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NeuroSense Therapeutics Ltd.
Principal Investigator
Jeremy Shefner, MD, PhD
Barrow Neurological Institute
Intervention
Fixed dose combination Ciprofloxacin/Celecoxib(drug)
Enrollment
10 enrolled
Eligibility
18-75 years · All sexes
Timeline
20192022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04090684 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials